Governance Moderna, Inc.

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-13 pm EST			Pre-market 08:04:40 am
39.60 ^USD	+17.02%		39.11	-1.24%

Jan. 13	US Equity Markets Fall as Investors Weigh Bank Earnings, December Inflation Data	MT
Jan. 13	PRESS DIGEST- Financial Times - January 13	RE

Executive Committee: Moderna, Inc.

Manager

Positions heldSince

Stéphane Bancel

53 year

Chief Executive Officer

2011-02-28

Jerh Collins

Chief Tech/Sci/R&D Officer

2022-12-31

James Mock

49 year

Director of Finance/CFO

2022-09-05

Shannon Klinger

55 year

General Counsel	2021-05-31
Corporate Secretary	2021-05-31

Jacqueline Miller

54 year

Chief Tech/Sci/R&D Officer

2024-11-06

Lavina Talukdar

Investor Relations Contact

2019-03-31

Tracey Franklin

46 year

Chief Tech/Sci/R&D Officer	2024-11-06
Human Resources Officer	2019-10-30

Stephen Hoge

50 year

President

2024-10-31

Composition of the Board of Directors: Moderna, Inc.

Director

CommitteesSince

Noubar Afeyan

62 year

Compensation Committee Chair	2004-12-31
Nominating Committee Chair	2004-12-31

Elizabeth Tallett

77 year

Audit Committee
Compensation Committee
HR Committee
Governance Committee	2011-05-31
Nominating Committee
Compensation Committee Chair	2010-12-31
Audit Committee Chair	2020-12-31

Elizabeth Nabel

74 year

Compensation Committee Chair
Compensation Committee
HR Committee
Audit Committee	2021-03-31
Governance Committee	2022-12-31
Nominating Committee	2022-12-31

Francois Nader

69 year

Compensation Committee Chair
HR Committee Chair
Governance Committee Chair	2019-12-10
Nominating Committee Chair	2019-12-10

Paul Sagan

67 year

Audit Committee	2020-12-31
Governance Committee	2021-01-31
Nominating Committee	2025-12-18
Compensation Committee	2025-12-18

Sandra Horning

77 year

Governance Committee	2020-11-12
Nominating Committee	2020-11-12

Shah Hussain

61 year

Audit Committee

2024-10-01

David Rubenstein

76 year

Audit Committee

2024-08-04

Stéphane Bancel

53 year

Director/Board Member

2011-02-28

Latest Appointments: Moderna, Inc.

Dec. 19	Okta, Inc. Announces Board Changes	CI
25-06-24	US CDC's report shows no evidence linking thimerosal-containing vaccines and autism	RE
25-06-11	Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	RE
25-06-11	Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	RE
25-05-06	US FDA names oncologist Vinay Prasad as top vaccine official	RE
25-03-31	Top Midday Decliners	MT
25-03-31	Pharma stocks sink after ouster of top FDA vaccine regulator	RE

More news

Former Officers and Directors: Moderna, Inc.

Insider

Positions held

SinceUntil

Kate Cronin

Corporate Officer/Principal

2021-07-11

2025-03-31

Melanie Ivarsson

Corporate Officer/Principal

2020-01-29

2024-10-31

Robert Langer

Director/Board Member	2010-11-30	2024-08-04
Founder	2009-12-31	2024-08-04
Independent Dir/Board Member	2010-11-30	2024-08-04

Stephen Berenson

Director/Board Member	2017-09-30	2024-08-04
Independent Dir/Board Member	2017-09-30	2024-08-04

Jonathan Hoggatt

Corporate Officer/Principal

2023-09-30

2024-05-31

Arpa Garay

Corporate Officer/Principal

2022-05-30

2023-12-07

Ronald Filippo

Corporate Officer/Principal

2021-08-31

2023-10-31

Juan Andres

Chief Tech/Sci/R&D Officer	2017-07-31	2022-12-31
Corporate Officer/Principal	2022-12-31	2023-05-30

Brad Miller

Chief Tech/Sci/R&D Officer

2023-01-02

Paul Burton

Chief Tech/Sci/R&D Officer

2021-07-05

2022-12-31

Stephanie Engels

Corporate Officer/Principal

2020-06-30

2022-10-31

Jorge Gomez

Director of Finance/CFO

2022-05-08

2022-05-09

David Meline

Director of Finance/CFO	2020-06-07	2022-05-08
Director of Finance/CFO	2022-05-09	2022-09-05

Corinne Le Goff

Corporate Officer/Principal

2021-01-18

2021-12-31

Marcello Damiani

Corporate Officer/Principal

2018-08-31

2021-12-31

Tal Zaks

Chief Tech/Sci/R&D Officer

2015-02-28

2021-07-05

Lori M. Henderson

General Counsel	2018-03-31	2021-05-31
Corporate Secretary	2018-03-31	2021-05-31

José M. Vega

Corporate Officer/Principal

2021-01-10

John Lepore

Corporate Officer/Principal

2020-08-09

Raymond C. Jordan

Corporate Officer/Principal

2020-06-14

Lorence Kim

Director of Finance/CFO	2014-03-31	2020-06-07
Investor Relations Contact	2014-03-31	2020-06-07

Patrick Norman Bergstedt

Corporate Officer/Principal

2020-05-31

Moncef Slaoui

Director/Board Member	2017-06-30	2020-05-14
Independent Dir/Board Member	2017-06-30	2020-05-14

Jennifer Ling Lee

Comptroller/Controller/Auditor

2020-01-01

Megan E. Pace

Corporate Officer/Principal

2018-03-31

2019-12-31

Peter Hutt

Director/Board Member	2012-02-29	2019-12-08
Independent Dir/Board Member	2012-02-29	2019-12-08

Jeffrey Cerio

Corporate Officer/Principal

2018-05-31

2019-10-31

Colleen Hussey

Public Communications Contact

2019-07-31

Robert Dolski

Corporate Officer/Principal

2016-05-31

2019-04-30

Anne Drapeau

Human Resources Officer

2016-09-30

2019-04-30

Stephen Harbin

Corporate Officer/Principal

2017-07-31

2019-03-31

Christoph Brackmann

Corporate Officer/Principal

2018-12-31

Theodore Ashburn

Corporate Officer/Principal

2017-08-31

2018-06-30

Richard J. Wanstall

Director of Finance/CFO

2014-06-30

2018-06-30

Giuseppe Ciaramella

Chief Tech/Sci/R&D Officer

2013-12-31

2018-01-31

Lee Cooper

Corporate Officer/Principal

2015-05-31

2017-12-30

Jason Glashow

Public Communications Contact

2017-11-30

Wendy Arnold

Human Resources Officer

2013-12-31

2017-11-30

Matthew Stanton

Corporate Officer/Principal

2014-03-31

2017-08-31

Barry Ticho

Corporate Officer/Principal

2016-01-31

2017-08-31

Saqib Islam

Corporate Officer/Principal

2016-01-31

2017-07-31

Henri A. Termeer

Director/Board Member

2017-05-11

Jim Kasinger

General Counsel	2014-03-31	2017-04-30
Corporate Secretary	2014-03-31	2017-04-30

Israel Ruiz

Director/Board Member	2017-01-31	-
Independent Dir/Board Member	2017-01-31	-

Francine Gregoire

Corporate Officer/Principal

2013-10-31

2016-02-29

Theo Melas-Kyriazi

Director/Board Member

2013-12-31

2015-12-31

Paula Soteropoulos

Corporate Officer/Principal

2013-06-30

2014-11-30

Louis St. Laurence O'Dea

Chief Tech/Sci/R&D Officer

2011-12-31

2014-05-31

John Mendlein

Director/Board Member	2019-01-31	-
Corporate Officer/Principal	2018-01-30	2019-01-31

Derrick J. Rossi

Founder

2009-12-31

Kenneth R. Chien

Founder

2009-12-31

John V. W. Reynders

Chief Tech/Sci/R&D Officer

Christine Swenson

General Counsel

Igor Smolenov

Chief Tech/Sci/R&D Officer

Douglas Cole

Director/Board Member	-	-
Founder	-	-

Leiden Dworak

Director/Board Member

Gregory Licholai

Corporate Officer/Principal

Axel Bouchon

Corporate Officer/Principal

Scott Sudduth

Corporate Officer/Principal

Paula Hammond

Consultant / Advisor

Joe Bolen

Chief Tech/Sci/R&D Officer	-	-
President	-	-

Kate Beresford O'Malley

Public Communications Contact

Age distribution of managers

Parity Men Women

Male	14
Female	3

Of which Executive Committee

Male	6
Female	2

Of which Directors

Male	8
Female	1

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (96.1%); - revenue from collaboration agreements (1.5%); - revenue from royalties and licensing (1.3%); - revenue from grants (1.1%). At the end of 2024, the group's portfolio comprises 37 products in clinical development, of which 10 in phase I, 18 in phase II and 9 in phase III, 3 products in preclinical development, and 4 products in commercial phase. Net sales are distributed geographically as follows: the United States (55.1%), Europe (18.5%) and other (26.4%).

Employees

5,800

Sector

Pharmaceuticals

Calendar

Feb. 12 - Q4 2025 Earnings Release

More about the company